CHEBI:67157 - α-L-Fuc-(1→2)-β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→3)-[α-L-Fuc-(1→2)-β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→6)]-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-D-GlcNAc

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name α-L-Fuc-(1→2)-β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→3)-[α-L-Fuc-(1→2)-β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→6)]-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-D-GlcNAc
ChEBI ID CHEBI:67157
ChEBI ASCII Name alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc
Definition An amino oligosaccharide comprising 4 fucose, 2 galactose, 4 N-acetyl glucosamine and 3 mannose residues arranged as two α-L-Fuc-(1→2)-β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-β-D-GlcNAc-(1→2)-α-D-Man brached chains linked (1→3) and (1→6)to a β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-D-GlcNAc trisaccaride chain.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C86H144N4O62
Net Charge 0
Average Mass 2226.05320
Monoisotopic Mass 2224.82381
InChI InChI=1S/C86H144N4O62/c1-18-39(103)50(114)58(122)78(129-18)146-67-37(89-24(7)101)76(139-32(15-97)65(67)144-84-72(56(120)45(109)27(10-92)135-84)151-80-60(124)52(116)41(105)20(3)131-80)149-70-54(118)43(107)26(9-91)134-83(70)128-17-34-47(111)69(62(126)82(141-34)143-64-31(14-96)138-75(36(49(64)113)88-23(6)100)142-63-30(13-95)133-74(127)35(48(63)112)87-22(5)99)148-86-71(55(119)44(108)29(12-94)137-86)150-77-38(90-25(8)102)68(147-79-59(123)51(115)40(104)19(2)130-79)66(33(16-98)140-77)145-85-73(57(121)46(110)28(11-93)136-85)152-81-61(125)53(117)42(106)21(4)132-81/h18-21,26-86,91-98,103-127H,9-17H2,1-8H3,(H,87,99)(H,88,100)(H,89,101)(H,90,102)/t18-,19-,20-,21-,26+,27+,28+,29+,30+,31+,32+,33+,34+,35+,36+,37+,38+,39+,40+,41+,42+,43+,44+,45-,46-,47+,48+,49+,50+,51+,52+,53+,54-,55-,56-,57-,58-,59-,60-,61-,62-,63+,64+,65+,66+,67+,68+,69-,70-,71-,72+,73+,74?,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86+/m0/s1
InChIKey NZXZKMZQGUNWED-RCPJTDSESA-N
SMILES C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]2O[C@@H]2[C@@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]3OC[C@H]3O[C@@H](O[C@H]4[C@H](O)[C@@H](NC(C)=O)[C@@H](O[C@@H]4CO)O[C@H]4[C@H](O)[C@@H](NC(C)=O)C(O)O[C@@H]4CO)[C@@H](O)[C@@H](O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O[C@@H]4O[C@H](CO)[C@@H](O[C@@H]5O[C@H](CO)[C@H](O)[C@H](O)[C@H]5O[C@@H]5O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]5O)[C@H](O[C@@H]5O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]5O)[C@H]4NC(C)=O)[C@@H]3O)[C@H](NC(C)=O)[C@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)[C@@H](O)[C@H](O)[C@@H]1O
Roles Classification
Biological Role(s): epitope
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
(via alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc )
View more via ChEBI Ontology
ChEBI Ontology
Outgoing α-L-Fuc-(1→2)-β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→3)-[α-L-Fuc-(1→2)-β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→6)]-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-D-GlcNAc (CHEBI:67157) has role epitope (CHEBI:53000)
α-L-Fuc-(1→2)-β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→3)-[α-L-Fuc-(1→2)-β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→6)]-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-D-GlcNAc (CHEBI:67157) is a amino oligosaccharide (CHEBI:22483)
α-L-Fuc-(1→2)-β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→3)-[α-L-Fuc-(1→2)-β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→6)]-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-D-GlcNAc (CHEBI:67157) is a glucosamine oligosaccharide (CHEBI:22485)
IUPAC Name
6-deoxy-α-L-galactopyranosyl-(1→3)-[6-deoxy-α-L-galactopyranosyl-(1→2)-β-D-galactopyranosyl-(1→4)]-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→2)-α-D-mannopyranosyl-(1→3)-[6-deoxy-α-L-galactopyranosyl-(1→3)-[6-deoxy-α-L-galactopyranosyl-(1→2)-β-D-galactopyranosyl-(1→4)]-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→2)-α-D-mannopyranosyl-(1→6)]-β-D-mannopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→4)-2-acetamido-2-deoxy-D-glucopyranose
Synonyms Sources
6-deoxy-α-L-galactosyl-(1→3)-[6-deoxy-α-L-galactosyl-(1→2)-β-D-galactosyl-(1→4)]-2-acetamido-2-deoxy-β-D-glucosyl-(1→2)-α-D-mannosyl-(1→3)-[6-deoxy-α-L-galactosyl-(1→3)-[6-deoxy-α-L-galactosyl-(1→2)-β-D-galactosyl-(1→4)]-2-acetamido-2-deoxy-β-D-glucosyl-(1→2)-α-D-mannosyl-(1→6)]-β-D-mannosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucosyl-(1→4)-2-acetamido-2-deoxy-D-glucose ChEBI
α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→2)-α-D-mannosyl-(1→3)-[α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→2)-α-D-mannosyl-(1→6)]-β-D-mannosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→4)-N-acetyl-D-glucosamine ChEBI
α-L-Fucp-(1→2)-β-D-Galp-(1→4)-[α-L-Fucp-(1→3)]-β-D-GlcpNAc-(1→2)-α-D-Manp-(1→3)-[α-L-Fucp-(1→2)-β-D-Galp-(1→4)-[α-L-Fucp-(1→3)]-β-D-GlcpNAc-(1→2)-α-D-Manp-(1→6)]-β-D-Manp-(1→4)-β-D-GlcpNAc-(1→4)-D-GlcpNAc IUPAC
Fuca1-2Galb1-4(Fuca1-3)GlcNAcb1-2Mana1-6(Fuca1-2Galb1-4(Fuca1-3)GlcNAcb1-2Mana1-3)Manb1-4GlcNAcb1-4GlcNAb
Note: (2020-03-12) Typo in original Table S2 of PMID:31537530. For GlcNAb read GlcNAc.
 ChEBI
Fucα1-2Galβ1-4(Fucα1-3)GlcNAcβ1-2Manα1-3[Fucα1-2Galβ1-4(Fucα1-3)GlcNAcβ1-2Manα1-6]Manβ1-4GlcNAcβ1-4GlcNAc ChEBI
WURCS=2.0/6,13,12/[a2122h-1x_1-5_2*NCC/3=O][a2122h-1b_1-5_2*NCC/3=O][a1122h-1b_1-5][a1122h-1a_1-5][a1221m-1a_1-5][a2112h-1b_1-5]/1-2-3-4-2-5-6-5-4-2-5-6-5/a4-b1_b4-c1_c3-d1_c6-i1_d2-e1_e3-f1_e4-g1_g2-h1_i2-j1_j3-k1_j4-l1_l2-m1 GlyTouCan
Manual Xrefs Databases
G40569DS GlyTouCan
G40569DS GlyGen
View more database links
Citations Waiting for Citations Types Sources
19443021 PubMed citation Europe PMC
31537530 PubMed citation Europe PMC
Last Modified
13 April 2021